![Michael A. Bober](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael A. Bober
Technik-/Wissenschafts-/F&E-Leiter bei TYRA BIOSCIENCES, INC.
Ursprung des Netzwerks ersten Grades von Michael A. Bober
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 21 | |
StillPoint Advisors, Inc.
![]() StillPoint Advisors, Inc. Miscellaneous Commercial ServicesCommercial Services StillPoint Advisors, Inc. provides wealth management services. The company's services include bill paying and accounting, tax planning & preparation, insurance, real estate management, and mortgage services. StillPoint Advisors was founded by Jim E. Thomas and is headquartered in Atlanta, GA
3
| Private Company | Miscellaneous Commercial Services | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Michael A. Bober
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
University of California San Diego | College/University | Graduate Degree Undergraduate Degree | |
NovaCardia, Inc.
![]() NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Director/Board Member Corporate Officer/Principal | |
CinRx Pharma LLC
![]() CinRx Pharma LLC Pharmaceuticals: MajorHealth Technology CinRx Pharma LLC develops biopharmaceutical products. It provides therapeutics in a novel way that meets the modern paradigm of drug development. The company was founded by Jonathan L. Isaacsohn in 2015 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director-Back Office Operation Chief Tech/Sci/R&D Officer | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
SIENNA BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Welltok, Inc.
![]() Welltok, Inc. Packaged SoftwareTechnology Services Welltok, Inc. is a consumer activation solutions company that improves people's total wellbeing. It offers proprietary data, advanced analytics, software-as-a-service software, and professional services to engage consumers in personalized and rewarding ways to drive action. The company was founded Jeff Cohen, Carlos C. Cardona, Scott Rotermund, Chris Rotermund, Christopher Coloian, Stanley J. Nowak III, Paulo Matos, Patrick D. Mize, and John DiBiasi in 2009 and is headquartered in Denver, CO. | Packaged Software | Director/Board Member | |
Primera Diagnostics, Inc.
![]() Primera Diagnostics, Inc. Medical SpecialtiesHealth Technology Primera Diagnostics, Inc. provides medical and diagnostics equipment and services. The company is headquartered in Providence, RI | Medical Specialties | Director/Board Member | |
CNS Therapeutics, Inc.
![]() CNS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology CNS Therapeutics, Inc. develops and manufactures drug delivery products. The company was founded in 2007 and is headquartered in St. Paul, MN. | Pharmaceuticals: Major | Director/Board Member | |
The Henry J. Kaiser Family Foundation
![]() The Henry J. Kaiser Family Foundation Investment Trusts/Mutual FundsMiscellaneous The Henry J. Kaiser Family Foundation, do-business-as Kaiser Family Foundation (KFF), is a non-profit, private operating foundation headquartered in San Francisco, California. The firm was founded in 1948, but it was completely remade in 1991. The foundation focuses on national health issues and the US role in global health policy. KFF develops and runs their own policy analysis, journalism and communications programs, sometimes in partnership with major news organizations. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Predilytics, Inc.
![]() Predilytics, Inc. Miscellaneous Commercial ServicesCommercial Services Predilytics, Inc. provides advanced healthcare analytic solutions. The firm engages in the provision of advanced healthcare analytic solutions to health plans, providers, and other risk-bearing entities. It applies its patented analytic tools to transform structured and unstructured client data, along with external data sources, into actionable insights. The company was founded by Hariharan Sundram and Chris Johnson in 2011 and is headquartered in Burlington, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Labrys Biologics, Inc.
![]() Labrys Biologics, Inc. BiotechnologyHealth Technology Labrys Biologics, Inc. provides biotechnology services. It is a venture-financed development stage biotechnology company, which focuses on treatments for chronic migraine. The company was founded by Corey S. Goodman in 2012 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Oracle Partners LP | Corporate Officer/Principal | ||
Stanford University | College/University | Undergraduate Degree | |
XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
InterWest Partners LLC
![]() InterWest Partners LLC Investment ManagersFinance InterWest Partners LLC (InterWest Partners) is a venture capital firm founded in 1979 by Wally Hawley, Scott Hedrick and Gene Barth. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor | |
Bay City Capital LLC
![]() Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Investment Managers | Chief Investment Officer | |
InterWest Management Partners IX LLC | Corporate Officer/Principal | ||
Kanisa Pharmaceuticals, Inc.
![]() Kanisa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kanisa Pharmaceuticals, Inc. develops pharmaceuticals and provides medical services. The company develops drugs for diagnosis and treatment of cancer. It was founded by David A. Socks and is located in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Precede Biosciences, Inc.
![]() Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Precede Biosciences is a company that aims to improve success rates in drug development and clinical practice by breaking down the barriers to precision medicine. The company is based in Boston, MA. The company seeks to redefine what can be learned from a simple blood draw to better target medicines to the right patients. Precede Biosciences is revolutionizing precision medicine by revealing unprecedented insights into disease-defining biology from a simple blood test. The CEO of the company is Rehan Verjee. | Miscellaneous Commercial Services | Chief Executive Officer | |
PANACEA ACQUISITION CORP. II | Financial Conglomerates | Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
DICE Molecules SV, Inc.
![]() DICE Molecules SV, Inc. Investment ManagersFinance DICE Molecules SV LLC engages in a biotechnology company. It focuses on the development of small moleculecompounds that act by unlocking protein-protein interfaces that have been intractable targets for orally bioavailable drugs. The company was founded by Pehr Harbury, Kevin Judice, John Bedbrook, and Phil Patten in 2013 and is headquartered in South San Francisco, CA. | Investment Managers | Director/Board Member | |
Xenikos BV
![]() Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Medical Specialties | Director/Board Member | |
Aavantibio, Inc.
![]() Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Biotechnology | Director/Board Member | |
JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
DICE THER | Biotechnology | Director/Board Member | |
Cedilla Therapeutics, Inc.
![]() Cedilla Therapeutics, Inc. BiotechnologyHealth Technology Cedilla Therapeutics, Inc. operats as a biotechnology company. It engages in discovering and exploiting insights into protein stability. The company was founded by Alan D. D?Andrea, Steve Gygi, Matthew P. Jacobson, William G. Kaelin, Jr. and Jack Taunton on September 6, 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
H.I.G. BioHealth Partners LLC
![]() H.I.G. BioHealth Partners LLC Investment ManagersFinance H.I.G. BioHealth Partners LLC (H.I.G. BioHealth Partners) is a private equity and venture capital subsidiary of H.I.G. Ventures LLC founded in 1993. The firm is headquartered in Miami, Florida with additional offices around the globe. | Investment Managers | Private Equity Investor | |
Boxer Capital LLC
![]() Boxer Capital LLC Investment ManagersFinance Boxer Capital LLC (Boxer Capital) is a venture capital subsidiary of Tavistock Group, Inc. founded in 2005 by Chris Fuglesang and Aaron I. Davis. The firm is headquartered in San Diego, California. | Investment Managers | Private Equity Investor | |
Rensselaer Polytechnic Institute | College/University | Undergraduate Degree | |
H.I.G. Capital LLC
![]() H.I.G. Capital LLC Financial ConglomeratesFinance H.I.G. Capital LLC operates as s a private equity and alternative assets investment firm. Its portfolio focuses in private equity, growth equity, real estate, debt or credit, lending, and bio health. The company was founded by Sami W. Mnaymneh and Anthony Tamer in 1993 and is headquartered in Miami, FL. | Financial Conglomerates | Corporate Officer/Principal | |
EMD Serono Canada, Inc. | Chief Executive Officer | ||
Nextech Invest AG
![]() Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | Investment Managers | Private Equity Analyst | |
ImaginAb, Inc.
![]() ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | Medical Specialties | Director/Board Member | |
Ambagon Therapeutics, Inc.
![]() Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
Alpha-9 Oncology, Inc.
![]() Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Director/Board Member | |
University of California, Los Angeles | College/University | Doctorate Degree | |
University of California, Davis | College/University | Undergraduate Degree | |
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
Vereinigte Staaten | 45 |
Kanada | 4 |
Niederlande | 2 |
Schweiz | 2 |
Deutschland | 2 |
Sektoral
Health Technology | 26 |
Finance | 10 |
Consumer Services | 8 |
Commercial Services | 5 |
Technology Services | 2 |
Operativ
Director/Board Member | 118 |
Corporate Officer/Principal | 32 |
Independent Dir/Board Member | 22 |
Undergraduate Degree | 17 |
Director of Finance/CFO | 11 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Nina Kjellson | 49 |
Robert More | 42 |
James Edward Thomas | 26 |
Alan Fuhrman | 17 |
Gilla Kaplan | 12 |
Jake Simson | 11 |
Hiroomi Tada | 9 |
James Winters | 7 |
Siddarth Subramony | 7 |
Melissa McCracken | 7 |
Rehan Verjee | 7 |
Todd Harris | 6 |
Piyush Patel | 6 |
Robert Hudkins | 5 |
Ali Fawaz | 5 |
- Börse
- Insiders
- Michael A. Bober
- Unternehmensverbindungen